Group 1 - The company held its 15th meeting of the 12th Board of Directors on September 1, 2025, with all 8 directors present, complying with legal and regulatory requirements [1][2] - The Board approved the appointment of Mr. Han Tongmin as the Vice General Manager, with a term lasting until the end of the current Board's tenure [1][2] - The Board also approved the appointment of Mr. Dang Guojun as the Chief Financial Officer, with a similar term duration [2][3] Group 2 - The Board made adjustments to the members of the Compensation and Assessment Committee, electing non-independent director Mr. Huang Junde as a member [2][3] - The voting results for all resolutions were unanimous, with 8 votes in favor and no votes against or abstentions [2][3]
天目药业: 杭州天目山药业股份有限公司第十二届董事会第十五次会议决议公告